| Efficacy of metabolically supported chemotherapy combined with ketogenic diet, hyperthermia, and hyperbaric oxygen therapy for stage IV triple-negative breast cancer MS İyikesici, AK Slocum, A Slocum, FB Berkarda, M Kalamian, ... Cureus 9 (7), 2017 | 76 | 2017 |
| Vascular endothelial growth factor, hypoxia-inducible factor 1 alpha and CD34 expressions in early-stage gastric tumors: relationship with pathological factors and prognostic … D Cabuk, G Basaran, C Celikel, F Dane, PF Yumuk, MS Iyikesici, ... Oncology 72 (1-2), 111-117, 2007 | 73 | 2007 |
| Feasibility study of metabolically supported chemotherapy with weekly carboplatin/paclitaxel combined with ketogenic diet, hyperthermia and hyperbaric oxygen therapy in … MS Iyikesici International Journal of Hyperthermia 36 (1), 445-454, 2019 | 62 | 2019 |
| Long-term survival outcomes of metabolically supported chemotherapy with gemcitabine-based or FOLFIRINOX regimen combined with ketogenic diet, hyperthermia, and hyperbaric … MS Iyikesici Complementary Medicine Research 27 (1), 31-39, 2020 | 48 | 2020 |
| Consideration of ketogenic metabolic therapy as a complementary or alternative approach for managing breast cancer TN Seyfried, P Mukherjee, MS Iyikesici, A Slocum, M Kalamian, ... Frontiers in Nutrition 7, 504037, 2020 | 47 | 2020 |
| Survival outcomes of metabolically supported chemotherapy combined with ketogenic diet, hyperthermia, and hyperbaric oxygen therapy in advanced gastric cancer MS İyikesici Nigerian Journal of Clinical Practice 23 (5), 734-740, 2020 | 30 | 2020 |
| Metabolically supported chemotherapy for managing end-stage breast cancer: a complete and durable response MS İyikesici, AK Slocum, N Winters, M Kalamian, TN Seyfried, NL Winters Cureus 13 (4), 2021 | 9 | 2021 |
| Complete response of locally advanced (stage III) rectal cancer to metabolically supported chemoradiotherapy with hyperthermia A Slocum Int J Cancer Res Mol Mech 2 (1), 2016 | 8 | 2016 |
| Associations between clinicopathological prognostic factors and pAkt, pMAPK and topoisomerase II expression in breast cancer MS Iyikesici, G Basaran, F Dane, M Ekenel, PF Yumuk, D Cabuk, ... International Journal of Clinical and Experimental Medicine 7 (5), 1459, 2014 | 8 | 2014 |
| Long-term outcomes of the treatment of unresectable (stageIII-IV) ductal pancreatic adenocarcinoma using metabolically supported chemotherapy (MSCT): A retrospective study M Iyikesici, A Slocum, E Turkmen, O Akdemir, T Ipek, E Eyuboglu, ... JOURNAL OF THE PANCREAS 17 (1), 2016 | 6 | 2016 |
| Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer. Frontiers in Nutrition, 7: 21 TN Seyfried, P Mukherjee, MS Iyikesici | 4 | 2020 |
| Preliminary results of metabolically supported chemotherapy combined with ketogenic diet, hyperthermia and hyperbaric oxygen therapy in stage II-IV rectal cancer MS İyikesici Archives of Clinical and Experimental Medicine 5 (1), 16-20, 2020 | 2 | 2020 |
| Response to Metabolically Supported Chemotherapy (MSCT) with weekly carboplatin/paclitaxel in advanced stage/metastatic (Stage IV) non-small cell lung cancer: A survival … MS Iyikesici, A Slocum, AK Slocum, E Turkmen, FB Berkarda Annals of Oncology 28, ii44, 2017 | 1 | 2017 |
| VEGF, HIF-1 alpha and CD34 expressions in gastric tumors (tms): Relationship with pathological factors and prognostic impact on survival D Cabuk, G Basaran, PF Yumuk, C Celikel, F Dane, MS Iyikesici, ... Journal of Clinical Oncology 23 (16_suppl), 4040-4040, 2005 | 1 | 2005 |
| Clinical features and outcome of adjuvant chemoradiotherapy in Turkish rectal carcinoma patients: Single institution experience F Dane, M Gumus, MA Ozturk, D Cabuk, MB Atasoy, PF Yumuk, ... Journal of Clinical Oncology 26 (15_suppl), 15103-15103, 2008 | | 2008 |
| Outcome of colon cancer patients receiving adjuvant chemotherapy in Marmara University Hospital F Dane, M Gumus, PF Yumuk, S Iyikesici, A Ozturk, G Basaran, HB Caglar, ... ANNALS OF ONCOLOGY 17, 130-130, 2006 | | 2006 |
| Meme kanserinde her-2/Neu ekspresyonu Ile pakt, Pmapk ve Topo II alfa ekspresyonları arasında ılişki MS İyikesici PQDT-Global, 2006 | | 2006 |
| Outcome of adjuvant treatment in turkish breast cancer (BC) patients (PTS): Single institution experience D Cabuk, G Basaran, S Iyikesici, M Ekenel, F Dane, M Teomete, M Gumus, ... ANNALS OF ONCOLOGY 17, 109-109, 2006 | | 2006 |
| Outcome of metastatic colorectal cancer patients receiving palliative chemotherapy in Marmara University Hospital F Dane, F Yumuk, M Gumus, S Iyikesici, A Tufan, G Basaran, D Cabuk, ... ANNALS OF ONCOLOGY 17, 129-129, 2006 | | 2006 |
| Outcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey M Teomete, PF Yumuk, MS Iyikesici, F Dane, G Basaran, D Cabuk, ... ANNALS OF ONCOLOGY 17, 225-226, 2006 | | 2006 |
